Kinaxis® (TSX:KXS, Financial), a leading provider of supply chain orchestration solutions, reported results for its second quarter ended June 30, 2024. All amounts are in U.S. dollars. All figures are prepared in accordance with IFRS Accounting Standards unless otherwise indicated.
“We delivered solid financial results in the quarter. Over three-quarters of business won was from new customers, and we are seeing good results from our heightened focused on profitability. For our larger enterprise opportunities, scrutiny around major buying decisions remains elevated and we anticipate that to remain over the short term. We are continuing to build for the long term. Our committed SaaS backlog grew 30% year over year, demand drivers are intensifying, and we are reinvesting in strategic go-to-market initiatives, positioning us for our next wave of strong, highly profitable growth,” said John Sicard, president and chief executive officer at Kinaxis. “Notwithstanding large enterprise deal delays, we closed record new customer wins for a Q2, and had record attendance at Kinexions, our supply chain community conference. At Kinexions, we introduced Maestro, our new AI-infused supply chain orchestration platform that breaks down silos across the entire network so our customers can conduct their supply chain in total harmony as they wrestle with increasing business complexity and disruption. The market is demanding better orchestration solutions and we are creating the path for them to follow.”
Q2 2024 Highlights
$ USD thousands, except as otherwise indicated | Q2 2024 | Q2 2023 | Change |
Total Revenue | 118,278 | 105,772 | 12% |
SaaS | 75,395 | 64,104 | 18% |
Subscription term licenses | 1,368 | 7,086 | (81)% |
Professional services | 36,495 | 29,991 | 22% |
Maintenance and support | 5,020 | 4,591 | 9% |
Gross profit | 70,186 | 63,670 | 10% |
Margin | 59% | 60% | |
Profit (loss) | 3,434 | (2,540) | _ |
Per diluted share | $0.12 | $(0.09) | |
Adjusted EBITDA1 | 21,930 | 15,202 | 44% |
Margin | 19% | 14% | |
Cash from operating activities | 13,140 | 13,943 | (6)% |
(1) “Adjusted EBITDA” is a non-IFRS measure and is not a recognized, defined or standardized measure under IFRS. This measure as well as any other non-IFRS financial measures reported by Kinaxis are defined in the “Non-IFRS Measures” section of this news release. | |||
Key Performance Indicators
The company’s Annual Recurring Revenue2 (ARR), which includes subscription amounts related to both SaaS and on-premise contracts, rose 15% to $339 million at the end of the quarter.
$USD millions | Q2 2024 | Q2 2023 | Change |
Annual recurring revenue2 | 339 | 293 | 15% |
| (2) Annual Recurring Revenue (ARR) is the total annualized value of recurring subscription amounts (ultimately recognized as SaaS, Subscription term licenses and Maintenance and support revenue) of all subscription contracts at a point in time. Annualized subscription amounts are determined solely by reference to the underlying contracts, normalizing for the varying revenue recognition treatments under IFRS 15 for cloud-based versus on-premise subscription amounts. It excludes one-time fees, such as for non-recurring professional services, and assumes that customers will renew the contractual commitments on a periodic basis as those commitments come up for renewal, unless such renewal is known to be unlikely. We believe that this measure provides a more current indication of our performance in the growth of our subscription business than other metrics. | |||
The nature of the company’s long-term contracts provides visibility into future, contracted revenue. The following table presents revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at June 30, 2024.
$USD millions | Remainder of 2024 | 2025 | 2026 and later | Total |
SaaS | 151.8 | 235.7 | 317.3 | 704.8 |
Maintenance and support | 10.1 | 15.3 | 16.4 | 41.8 |
Subscription term licenses | 1.6 | 0.1 | 0.1 | 1.8 |
Total | 163.5 | 251.1 | 333.8 | 748.4 |
Financial Guidance
Kinaxis is updating its fiscal 2024 guidance, as follows:
FY 2024 Guidance | |
Total revenue | $483-495 million |
SaaS | 15-17% growth |
Subscription term license | $9-11 million |
Adjusted EBITDA1 margin | 19-21% |
“I’m pleased to increase our Adjusted EBITDA guidance for fiscal 2024 for the second consecutive quarter. While elevated scrutiny in the buying environment, particularly for the largest deals, and fluctuations in certain key foreign currencies, have tempered our SaaS revenue outlook for 2024, we're confidently moving towards our 25% Adjusted EBITDA mid-term target. We look forward to a more typical buying environment and seeing the impacts of reinvestment in strategic go-to-market initiatives,” said Blaine Fitzgerald, chief financial officer at Kinaxis.
Guidance in this press release is provided to enhance visibility into Kinaxis’ expectations for financial targets for the periods indicated. Please refer to the section regarding forward-looking statements that forms an integral part of this release. This press release along with the financial statements and MD&A for the quarter ended June 30, 2024 are available on Kinaxis’ website and on SEDAR at www.sedar.com.
Conference Call
Kinaxis will host a conference call tomorrow, August 1, 2024, to discuss these results. John Sicard, chief executive officer, and Blaine Fitzgerald, chief financial officer, will host the call starting at 8:30 a.m. Eastern Time. A question and answer session will follow management's presentation. Investors and participants must register for the call in advance. See registration link below. Please call the conference telephone number fifteen minutes prior to the start time.
DATE: | Thursday, August 1, 2024 | |
TIME: | 8:30 a.m. Eastern Time | |
CALL REGISTRATION: | ||
WEBCAST | https://events.q4inc.com/attendee/304263983 (available for three months) |
About Kinaxis Inc.
Kinaxis is a global leader in modern supply chain orchestration. We serve supply chains and the people who manage them in service of humanity. Our software is trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. We combine our patented concurrency technique with a human-centered approach to AI to empower businesses of all sizes to orchestrate their end-to-end supply chain network, from multi-year strategic planning through down-to-the-second execution and last-mile delivery. For more news and information, please visit kinaxis.com or follow us on LinkedIn.
Non-IFRS Measures
This press release makes reference to Adjusted Profit and Adjusted EBITDA, which are non-IFRS financial measures, as well as Adjusted EBITDA margin which expresses Adjusted EBITDA as a percentage of revenue. Adjusted Profit, Adjusted EBITDA and Adjusted EBITDA margin are not recognized, defined or standardized measures under IFRS. We use these measures to provide investors with supplemental information on our operating performance and to highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. We believe that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability to meet our capital expenditure and working capital requirements, and to determine components of employee compensation.
Adjusted Profit represents profit adjusted to exclude the changes in the fair value of contingent consideration, our equity compensation plans and non-recurring items. Adjusted EBITDA represents profit adjusted to exclude the change in the fair value of contingent consideration, our equity compensation plans, non-recurring items, income tax expense, depreciation and amortization, foreign exchange loss (gain) and net finance (income) expense. Adjusted EBITDA margin expresses Adjusted EBITDA as a percentage of revenue. Our definitions of Adjusted Profit, Adjusted EBITDA and Adjusted EBITDA margin will likely differ from those used by other companies (including our peers) and therefore comparability may be limited. Non-IFRS measures should not be considered a substitute for or in isolation from measures prepared in accordance with IFRS. Investors are encouraged to review our financial statements and disclosures in their entirety and are cautioned not to put undue reliance on non-IFRS measures and view them in conjunction with the most comparable IFRS financial measures. Kinaxis has reconciled Adjusted Profit and Adjusted EBITDA to the most comparable IFRS financial measure as follows:
Three months ended June 30, | Six months ended June 30, 2024 | |||||||||
2024 | 2023 | 2024 | 2023 | |||||||
(In thousands of USD) | (In thousands of USD) | |||||||||
Profit (loss) | 3,434 | (2,540) | 9,621 | (1,351) | ||||||
Change in fair value of contingent consideration | — | 462 | — | 2,656 | ||||||
Share-based compensation | 7,702 | 9,155 | 16,424 | 17,374 | ||||||
Non-recurring item3 | 5,546 | — | 7,298 | — | ||||||
Adjusted profit | 16,682 | 7,077 | 33,343 | 18,679 | ||||||
Income tax expense | 2,082 | 997 | 4,691 | 1,301 | ||||||
Depreciation and amortization | 6,268 | 6,517 | 12,673 | 13,404 | ||||||
Foreign exchange gain (loss) | (40) | 2,374 | (166) | 2,109 | ||||||
Net finance income | (3,062) | (1,763) | (5,931) | (3,149) | ||||||
5,248 | 8,125 | 11,267 | 13,665 | |||||||
Adjusted EBITDA | 21,930 | 15,202 | 44,610 | 32,344 | ||||||
Adjusted EBITDA Margin | 19% | 14% | 19% | 16% | ||||||
Note: (3) Costs associated with the restructuring initiative | ||||||||||
Forward-Looking Statements
Certain statements in this release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements as to our expectations for:
- growth of annual total revenue, annual SaaS and Subscription term licenses revenue, and our expectations for Adjusted EBITDA margin achievement, in each case looking forward for our fiscal year ending December 31, 2024;
- SaaS growth and increased profitability in years beyond 2024; and
- contracted revenue in future periods, including 2024, 2025 and 2026 and later.
This release also includes forward-looking statements as to Kinaxis’ growth opportunities and the potential benefits of, and markets and demand for, Kinaxis’ products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxis’ products and services compared to competitive offerings in the industry.
In particular, our guidance for 2024 annual total revenue, annual SaaS and Subscription term license revenue and annual Adjusted EBITDA margin, as well as our comments on our expectations for SaaS growth and increased profitability in years beyond 2024, are subject to certain assumptions and associated risks including:
- our ability to win business from new customers and expand business from existing customers;
- the timing of new customer wins and expansion decisions by our existing customers;
- maintaining our customer retention levels, and specifically, that customers will renew contractual commitments on a periodic basis as those commitments come up for renewal, at rates consistent with our historic experience;
- fluctuations in the value of foreign currencies relative to the U.S. Dollar; and
- with respect to Adjusted EBITDA and profitability, our ability to contain expense levels while expanding our business.
Our guidance and commentary for achievement of contracted revenue in future periods, including in 2024, 2025 and 2026 and later, is based on assumptions and associated risks including:
- our ability to satisfy material unperformed obligations under our long-term contracts; and
- the continued financial capacity and creditworthiness of our customers under long-term contracts.
These and other assumptions, risks and uncertainties may cause Kinaxis’ actual results, performance, achievements and developments to differ materially from the results, performance, achievements or developments expressed or implied by forward-looking statements. Material risks and uncertainties relating to our business are described under the headings “Forward-Looking Statements” and “Risks and Uncertainties” in our annual MD&A dated February 28, 2024, under the heading “Risk Factors” in our Annual Information Form dated March 25, 2024 and in our other public documents filed with Canadian securities regulatory authorities, which are available at www.sedarplus.ca. Forward-looking statements are provided to help readers understand management’s expectations as at the date of this release and may not be suitable for other purposes. Readers are cautioned not to place undue reliance on forward-looking statements. Kinaxis assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.
SOURCE: Kinaxis Inc.
Kinaxis Inc. Condensed Consolidated Interim Statements of Financial Position (Expressed in thousands of USD) (Unaudited) | ||||
June 30, 2024 | December 31, 2023 | |||
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | $ | 147,155 | $ | 174,844 |
Short-term investments | 135,176 | 118,118 | ||
Trade and other receivables | 145,785 | 156,609 | ||
Prepaid expenses | 17,623 | 14,810 | ||
445,739 | 464,381 | |||
Non-current assets: | ||||
Unbilled receivables | 1,710 | 3,155 | ||
Other receivables | 865 | 972 | ||
Prepaid expenses | 2,406 | 1,130 | ||
Investment tax credits recoverable | 10,371 | 8,362 | ||
Deferred tax assets | 35,088 | 1,184 | ||
Contract acquisition costs | 29,784 | 27,438 | ||
Property and equipment | 35,858 | 40,300 | ||
Right-of-use assets | 47,930 | 47,109 | ||
Intangible assets | 20,343 | 23,394 | ||
Goodwill | 73,613 | 74,556 | ||
257,968 | 227,600 | |||
$ | 703,707 | $ | 691,981 | |
Liabilities and Shareholders’ Equity | ||||
Current liabilities: | ||||
Trade payables and accrued liabilities | 93,537 | 39,700 | ||
Provisions | 875 | — | ||
Deferred revenue | 133,909 | 137,598 | ||
Lease obligations | 5,930 | 5,805 | ||
234,251 | 183,103 | |||
Non-current liabilities: | ||||
Lease obligations | 45,664 | 45,985 | ||
Deferred tax liabilities | 7,677 | 8,065 | ||
53,341 | 54,050 | |||
Shareholders’ equity: | ||||
Share capital | 294,878 | 307,327 | ||
Contributed surplus | 11,128 | 44,339 | ||
Accumulated other comprehensive income (loss) | (1,314) | 1,360 | ||
Retained earnings | 111,423 | 101,802 | ||
416,115 | 454,828 | |||
$ | 703,707 | $ | 691,981 | |
Kinaxis Inc. Condensed Consolidated Interim Statements of Comprehensive Income (Expressed in thousands of USD, except share and per share data) (Unaudited) | ||||||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
Revenue | $ | 118,278 | $ | 105,772 | $ | 237,648 | $ | 206,902 | ||||
Cost of revenue | 48,092 | 42,102 | 94,532 | 82,231 | ||||||||
Gross profit | 70,186 | 63,670 | 143,116 | 124,671 | ||||||||
Operating expenses: | ||||||||||||
Selling and marketing | 27,341 | 28,417 | 52,268 | 52,581 | ||||||||
Research and development | 22,221 | 21,002 | 45,206 | 40,931 | ||||||||
General and administrative | 18,263 | 14,777 | 37,512 | 29,568 | ||||||||
67,825 | 64,196 | 134,986 | 123,080 | |||||||||
2,361 | (526 | ) | 8,130 | 1,591 | ||||||||
Other income (expense): | ||||||||||||
Foreign exchange gain (loss) | 40 | (2,374 | ) | 166 | (2,109 | ) | ||||||
Net finance and other income | 3,115 | 1,819 | 6,016 | 3,124 | ||||||||
Change in fair value of contingent consideration | — | (462 | ) | — | (2,656 | ) | ||||||
3,155 | (1,017 | ) | 6,182 | (1,641 | ) | |||||||
Profit (loss) before income taxes | 5,516 | (1,543 | ) | 14,312 | (50 | ) | ||||||
Income tax expense | 2,082 | 997 | 4,691 | 1,301 | ||||||||
Profit (loss) | 3,434 | (2,540 | ) | 9,621 | (1,351 | ) | ||||||
Other comprehensive income (loss): | ||||||||||||
Items that are or may be reclassified subsequently to profit (loss): | ||||||||||||
Foreign currency translation differences - foreign operations | (621 | ) | (423 | ) | (1,956 | ) | 289 | |||||
Change in valuation of cash flow hedges | (241 | ) | 154 | (718 | ) | 231 | ||||||
(862 | ) | (269 | ) | (2,674 | ) | 520 | ||||||
Total comprehensive income (loss) | $ | 2,572 | $ | (2,809 | ) | $ | 6,947 | $ | (831 | ) | ||
Basic earnings (loss) per share | $ | 0.12 | $ | (0.09 | ) | $ | 0.34 | $ | (0.05 | ) | ||
Weighted average number of basic Common Shares | 28,187,236 | 28,318,956 | 28,232,707 | 28,181,727 | ||||||||
Diluted earnings (loss) per share | $ | 0.12 | $ | (0.09 | ) | $ | 0.33 | $ | (0.05 | ) | ||
Weighted average number of diluted Common Shares | 28,787,603 | 28,318,956 | 28,875,785 | 28,181,727 | ||||||||
Kinaxis Inc. Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity (Expressed in thousands of USD) (Unaudited) | ||||||||||||||||||||
Accumulated other comprehensive income (loss) | ||||||||||||||||||||
Share capital | Contributed surplus | Cash flow hedges | Currency translation adjustments | Total | Retained earnings | Total equity | ||||||||||||||
Balance, December 31, 2022 | $ | 244,713 | $ | 65,129 | $ | — | $ | (156 | ) | $ | (156 | ) | $ | 91,742 | $ | 401,428 | ||||
Profit | — | — | — | — | — | 10,060 | 10,060 | |||||||||||||
Other comprehensive income | — | — | 441 | 1,075 | 1,516 | — | 1,516 | |||||||||||||
Total comprehensive income | — | — | 441 | 1,075 | 1,516 | 10,060 | 11,576 | |||||||||||||
Share options exercised | 41,545 | (9,991 | ) | — | — | — | — | 31,554 | ||||||||||||
Restricted share units vested | 10,676 | (10,676 | ) | — | — | — | — | — | ||||||||||||
Performance share units vested | 2,628 | (2,628 | ) | — | — | — | — | — | ||||||||||||
Share-based payments | — | 35,788 | — | — | — | — | 35,788 | |||||||||||||
Shares issued for contingent consideration | 11,097 | — | — | — | — | — | 11,097 | |||||||||||||
Shares repurchased | (3,332 | ) | (33,283 | ) | — | — | — | — | (36,615 | ) | ||||||||||
Total shareholder transactions | 62,614 | (20,790 | ) | — | — | — | — | 41,824 | ||||||||||||
Balance, December 31, 2023 | $ | 307,327 | $ | 44,339 | $ | 441 | $ | 919 | $ | 1,360 | $ | 101,802 | $ | 454,828 | ||||||
Profit | — | — | — | — | — | 9,621 | 9,621 | |||||||||||||
Other comprehensive loss | — | — | (718 | ) | (1,956 | ) | (2,674 | ) | — | (2,674 | ) | |||||||||
Total comprehensive income (loss) | — | — | (718 | ) | (1,956 | ) | (2,674 | ) | 9,621 | 6,947 | ||||||||||
Share options exercised | 14,824 | (3,516 | ) | — | — | — | — | 11,308 | ||||||||||||
Restricted share units vested | 7,387 | (7,387 | ) | — | — | — | — | — | ||||||||||||
Deferred share units vested | 1,396 | (1,396 | ) | — | — | — | — | — | ||||||||||||
Performance share units vested | 5,533 | (5,533 | ) | — | — | — | — | — | ||||||||||||
Share-based payments | — | 16,616 | — | — | — | — | 16,616 | |||||||||||||
Shares repurchased | (25,412 | ) | (31,995 | ) | — | — | — | — | (57,407 | ) | ||||||||||
Obligation related to share repurchases | (16,177 | ) | — | — | — | — | — | (16,177 | ) | |||||||||||
Total shareholder transactions | (12,449 | ) | (33,211 | ) | — | — | — | — | (45,660 | ) | ||||||||||
Balance, June 30, 2024 | $ | 294,878 | $ | 11,128 | $ | (277 | ) | $ | (1,037 | ) | $ | (1,314 | ) | $ | 111,423 | $ | 416,115 | |||
Kinaxis Inc. Condensed Consolidated Interim Statements of Cash Flows (Expressed in thousands of USD) (Unaudited) | ||||||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
Cash flows from operating activities: | ||||||||||||
Profit (loss) | $ | 3,434 | $ | (2,540 | ) | $ | 9,621 | $ | (1,351 | ) | ||
Items not affecting cash: | ||||||||||||
Depreciation of property and equipment and right-of-use assets | 4,942 | 5,186 | 10,018 | 10,661 | ||||||||
Amortization of intangible assets | 1,326 | 1,331 | 2,655 | 2,743 | ||||||||
Share-based payments | 7,702 | 9,155 | 16,424 | 17,374 | ||||||||
Net finance income | (3,062 | ) | (1,763 | ) | (5,931 | ) | (3,149 | ) | ||||
Change in fair value of contingent consideration | — | 462 | — | 2,656 | ||||||||
Income tax expense | 2,082 | 997 | 4,691 | 1,301 | ||||||||
Investment tax credits recoverable | (1,109 | ) | (494 | ) | (2,009 | ) | (1,409 | ) | ||||
Change in operating assets and liabilities | (2,904 | ) | 1,587 | 6,203 | 24,546 | |||||||
Interest received | 3,778 | 1,934 | 8,188 | 3,195 | ||||||||
Interest paid | (459 | ) | (415 | ) | (841 | ) | (848 | ) | ||||
Income taxes paid | (2,590 | ) | (1,497 | ) | (3,868 | ) | (2,871 | ) | ||||
13,140 | 13,943 | 45,151 | 52,848 | |||||||||
Cash flows from (used in) investing activities: | ||||||||||||
Purchase of property and equipment and intangible assets | (1,893 | ) | (769 | ) | (2,084 | ) | (1,632 | ) | ||||
Purchase of short-term investments | (157,512 | ) | (45,588 | ) | (216,869 | ) | (100,671 | ) | ||||
Redemption of short-term investments | 105,832 | 45,154 | 198,395 | 60,160 | ||||||||
(53,573 | ) | (1,203 | ) | (20,558 | ) | (42,143 | ) | |||||
Cash flows from (used in) financing activities: | ||||||||||||
Payment of lease obligations | (1,786 | ) | (1,737 | ) | (3,526 | ) | (3,556 | ) | ||||
Repurchase of shares | (36,125 | ) | — | (57,407 | ) | — | ||||||
Proceeds from exercise of stock options | 7,126 | 9,133 | 11,308 | 19,644 | ||||||||
(30,785 | ) | 7,396 | (49,625 | ) | 16,088 | |||||||
Increase (decrease) in cash and cash equivalents | (71,218 | ) | 20,136 | (25,032 | ) | 26,793 | ||||||
Cash and cash equivalents, beginning of period | 219,374 | 181,566 | 174,844 | 175,347 | ||||||||
Effects of exchange rates on cash and cash equivalents | $ | (1,001 | ) | $ | (94 | ) | (2,657 | ) | (532 | ) | ||
Cash and cash equivalents, end of period | 147,155 | 201,608 | $ | 147,155 | $ | 201,608 | ||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20240731357178/en/
